AzTrials
AzTrials

Lupus Erythematosus, SystemicNCT05379725

Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

A study testing Mediterranean Dietary Pattern and High Fermented Food Dietary Pattern in people with Lupus Erythematosus, Systemic, run by University of Florida at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE). Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Lupus Erythematosus, Systemic
What is being tested?
Mediterranean Dietary Pattern and High Fermented Food Dietary Pattern
Could I receive a placebo?
No, everyone receives an active treatment
How many people
5 participants
Where
1 siteUnited States
Study dates
22 Mar 2022to 1 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • > 18 years of age
  • Able to provide informed consent and undertake study questionnaire completion in English
  • Meets SLE diagnostic criteria and is currently under the care of a rheumatologist, nephrologist, or other physician regarding SLE care
  • Be willing and able to comply with all the study-related procedures

Who cannot join

  • Pregnant or planning pregnancy within the duration of the interventional study.
  • Currently following a vegetarian/vegan diet.
  • Allergy/sensitivity to gluten, soy, or cow's milk.
  • Self-disclosure of lactose intolerance
  • Inability to comply with the study procedures.
  • Baseline dietary fiber intake > 30 g/day
  • MEDAS score at baseline > 9
  • Baseline consumption of > 2 servings per day of fermented foods

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Florida/UF Health

    Gainesville, Florida, 32611

Other trials in United States

About this study

Official title: Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation and Disease Activity in Systemic Lupus Erythematosus

This is a 4-month randomized controlled trial to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with Systemic lupus erythematosus (SLE).

Read the detailed description

Given the demonstrated beneficial effects of the Mediterranean dietary pattern in autoimmune disease and the potential benefit of a high-fermented-food diet on inflammatory profiles, we aim to determine the feasibility and relative benefit of a Mediterranean dietary pattern versus a high-fermented-food diet on inflammatory markers and clinical outcomes in individuals with SLE. The primary aim of the study is to evaluate the feasibility of 'good and very good' adherence to the Mediterranean dietary pattern and to a high-fermented-food diet by individuals with SLE. Secondary aims will determine the effects of the Mediterranean dietary pattern and a high-fermented-food diet on attenuating inflammation and disease activity in individuals with SLE. This is a 4-month randomized controlled trial with a 1-month baseline of usual diet and 3-month intervention. Participants will complete the online DHQ III and diet adherence questionnaires monthly. Blood will be obtained at randomization and at the end of the intervention period for analysis of inflammatory cytokines. Dietary intake during baseline and intervention will be assessed by 5, ASA 24-h dietary recalls.

Being tested
Mediterranean Dietary Pattern, High Fermented Food Dietary Pattern
Keywords
SLE, Lupus, Mediterranean diet, Fermented food, Inflammation
Medical subject headings
Lupus Erythematosus, Systemic, Inflammation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mediterranean Dietary PatternOther

    The Mediterranean dietary pattern includes whole or minimally processed foods with a high intake of vegetables, fruits, whole grains, fish, and olive oil.

  • High Fermented Food Dietary PatternOther

    Fermented foods such as yogurt, kefir, fermented cottage cheese, fermented vegetables, vegetable brine drinks, kombucha, other fermented non-alcoholic drinks, and other foods will be recommended.

Study groups in NCT05379725
Study groupRoleWhat they receive
Mediterranean dietExperimentalParticipants will receive diet education on adherence to a Mediterranean dietary pattern.
Receives: Other: Mediterranean Dietary Pattern
Fermented foodExperimentalParticipants will receive diet education on adherence to a high fermented food dietary pattern.
Receives: Other: High Fermented Food Dietary Pattern

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence - Mediterranean Diet

    Percent of participants achieving 'good to very good adherence') as assessed by the 14-day Mediterranean diet questionnaire (MEDAS) score

    Measured: baseline, month 1, 2 and 3

  2. Adherence - Fermented Food Diet

    Percent of participants achieving > 5 servings of fermented foods per day

    Measured: baseline, month 1, 2, and 3

Secondary outcomes (6)
  1. Diet Quality

    Healthy Eating Index 2015 score (0 minimum to 100 maximum). Higher values indicate better diet quality.

    Measured: baseline, month 3

  2. Systemic Lupus Erythematosus Disease Activity

    Systemic Lupus Erythematosus disease activity using the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) score (0 minimum and 105 maximum, with higher scores representing higher disease activity.

    Measured: baseline, month 3

  3. ESR

    Erythrocyte sedimentation rate

    Measured: baseline, month 3

  4. hsCRP

    high-sensitivity C-reactive protein

    Measured: baseline, month 3

  5. anti-dsDNA

    Anti-double stranded DNA

    Measured: baseline, month 3

  6. Cytokine profile

    Cytokines profile e.g., interleukin-18 (IL-18), tumor necrosis factor (TNF), IL-6, IL-2, IL-10

    Measured: baseline, month 3

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 May 2022
  2. Study start22 Mar 2022
  3. Primary completion1 Mar 2025
  4. Study completion1 Mar 2025

Why it stopped: Lack of funding to continue.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
5 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05379725
Sponsor's protocol ID
IRB202200703
Status last verified
Jun 2025
First submitted
9 May 2022
Last updated
26 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Mediterranean Dietary Pattern and High Fermented Food Dietary Pattern in people with Lupus Erythematosus, Systemic, run by University of Florida at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of funding to continue.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence - Mediterranean Diet (time frame: baseline, month 1, 2 and 3). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in